Latest From Biotech Now

Blurred Lines: Investors Explain Their Re-Thinking of Traditional Private-Only or Public-Only Investment Strategies


The recent expansion and acceleration of the biotech stock market has seen a new willingness and in some cases eagerness to pursue crossover investing in firms pre- and post-IPO. Venture capitalists have become less dogmatic about funding stage and equity share when positive returns seem nearly guaranteed and investment banks are engaging in discussions with entrepreneurs earlier than ever. Relatedly, corporate venture capital executives’ missions have broadened to consider more diverse forms of collaboration than Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Electroceuticals and Digital Drug Delivery: Neurological Stimulation and Beyond

electroceuticals panel

Some of the most experienced executives in biotechnology have begun asking themselves, “Can we foresee the day of diminishing returns from research in traditional molecular biology?” These researchers are investigating alternative modalities of providing therapy that would combine electronic sensing with drug delivery or even stimulating the body through electricity alone to produce a desired response. These “electroceutical,” or “bioelectronics,” approaches have produced exciting results in early clinical trials, particularly related to insulin control and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Biotech CEOs Talk JOBS Act and IPO Experiences at 2014 BIO Investor Forum

Biotech IPOs Infographic

The JOBS Act has contributed to a dramatic acceleration in new biotech IPOs since its passage, with nearly a tripling in the rate of companies going public in the industry. By changing how entrepreneurs can access and communicate with investors earlier in the process, the JOBS Act has fundamentally shifted how CEOs of discovery-driven companies must spend their time dealing with internal versus external priorities. Yesterday at the 2014 BIO Investor Forum, a panel of Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Upcoming Panel will Highlight The Successes of The NCATS Tech Transfer Model

U.S. Capitol Building - Congress

On October 29, 2014 the Center for Clean Energy Innovation and the House Technology Transfer Caucus will be hosting a panel of experts to discuss NIH’s NCATS program and its impact on the tech transfer policy debate. One of the biggest challenges for federally funded research and technology is bridging the development “Valley of Death.” Despite their tremendous potential impact, many promising discoveries die during development due to their insufficient advancements, which detract private investment. Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

GMO Answers Marks October as “Get to Know GMOs” Month

GMO Answers

GMO Answers has announced that for the month of October we are inviting the public to “Get to Know GMOs” – to ask their toughest questions and join the conversation. This month GMO Answers will be engaging online and across social media to help consumers Get to Know GMOs and better understand the role of biotechnology in agriculture. As others promote activities opposing GMOs throughout October, we’ll be correcting common misconceptions and introducing consumers to those Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , ,